Leukemia Research
Volume 24, Issue 12 , Pages 1049-1057, December 2000

PMA-treated K-562 leukemia cells mediate a TH2-specific expansion of CD4+ T cells in vitro

  • Erich J Baker

      Affiliations

    • Department of Medical Biology, Graduate School of Medicine, University of Tennessee Medical Center at Knoxville, 1924 Alcoa Highway, Knoxville, TN 37920, USA
  • ,
  • Albert T Ichiki

      Affiliations

    • Department of Medical Biology, Graduate School of Medicine, University of Tennessee Medical Center at Knoxville, 1924 Alcoa Highway, Knoxville, TN 37920, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-865-5449467; fax: +1-865-5449460
  • ,
  • James W Hodge

      Affiliations

    • National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
  • ,
  • Devadas Sugantharaj

      Affiliations

    • Department of Medical Biology, Graduate School of Medicine, University of Tennessee Medical Center at Knoxville, 1924 Alcoa Highway, Knoxville, TN 37920, USA
  • ,
  • Elena G Bamberger

      Affiliations

    • Department of Medical Biology, Graduate School of Medicine, University of Tennessee Medical Center at Knoxville, 1924 Alcoa Highway, Knoxville, TN 37920, USA
  • ,
  • Carmen B Lozzio

      Affiliations

    • Department of Medical Biology, Graduate School of Medicine, University of Tennessee Medical Center at Knoxville, 1924 Alcoa Highway, Knoxville, TN 37920, USA

Received 17 February 2000; accepted 16 June 2000.

Abstract 

Highly enriched preparations of human CD3+CD4+ T-lymphocytes were stimulated with mitogen or OKT3 to determine the capacity of K-562 cells to function as accessory cells. Phorbol 12-myristate 13-acetate (PMA)-treated K-562 cells were induced to differentiate along the megakaryocytic lineage and could supplant monocyte-accessory cell function. Intracytoplasmic analysis of interleukin-4 (IL-4) and interferon-γ (IFN-γ) established that IL-4, and not IFN-γ, was preferentially produced by the activated lymphocytes. This polarized stimulation is compatible with a type 2 or humoral immune response of purified T cells co-cultured with differentiated K-562 cells in vitro, and may have implications in immunoregulation due to disease progression.

Keywords:  Human CD4 cells, Phorbol 12-myristate 13-acetate, K-562, Th1, Th2

Abbreviations:  APC, antigen-presenting cell, CML, chronic myelogenous leukemia, ConA, concanavalin A, FBS, fetal bovine serum, FITC, fluoroscein isothiocyanate, IFN-γ, interferon-γ, IL, interleukin, KLH, keyhole limpet hemocyanin, MHC, major histocompatibility complex, PBS, phosphate-buffered saline, PE, phycoerythrin, PHA, phytohemagglutinin, PMA, phorbol 12-myristate 13-acetate, TCR, T cell receptor, Th1, T helper lymphocyte type 1, Th2, T helper lymphocyte type 2

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0145-2126(00)00082-5

doi:10.1016/S0145-2126(00)00082-5

Leukemia Research
Volume 24, Issue 12 , Pages 1049-1057, December 2000